Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001415889-25-009604

Director bought 35,640 shares at $0.56 ($19,958)

From the SEC's structured data for this filing

Trades in this filing

BRAWLEY OTIS W · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-31 Purchase : show line 1 in the form +35,640 $0.56 $19,958 35,640 D
Open-market purchases · 35,640 sh · avg $0.56 · $19,958
Loading xslF345X05/form4-04022025_070458.xml…